Brian M. Andersen, Ph.D.
Affiliations: | Neuroscience | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Stem cellsGoogle:
"Brian Andersen"Mean distance: 23748
Parents
Sign in to add mentor| Walter C. Low | grad student | 2013 | UMN | |
| (The role of oxygen in the immunogenicity of brain tumor cell vaccines.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Moertel CL, Xia J, LaRue R, et al. (2014) CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy. Journal For Immunotherapy of Cancer. 2: 46 |
| Olin MR, Pluhar GE, Andersen BM, et al. (2014) Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art. Critical Reviews in Immunology. 34: 399-432 |
| Pluhar L, Olin M, Goulart M, et al. (2014) PM-17INTRACEREBRAL IFN-γ DOES NOT ENHANCE THE RESPONSE TO VACCINE IMMUNOTHERAPY FOR CANINE GLIOMA Neuro-Oncology. 16 |
| Andersen BM, Pluhar GE, Seiler CE, et al. (2013) Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicity. Cancer Research. 73: 2987-97 |
| Ohlfest JR, Andersen BM, Litterman AJ, et al. (2013) Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model. Journal of Immunology (Baltimore, Md. : 1950). 190: 613-20 |
| Andersen BM, Pluhar GE, Seiler CE, et al. (2013) Abstract B32: Preclinical testing of three immune adjuvants in vaccination therapy for invasive canine meningioma. Cancer Research. 73 |
| Goulart M, Pluhar E, Andersen B, et al. (2013) Abstract B20: Immunotherapy as treatment for dogs with glioma. Cancer Research. 73 |
| Andersen BM, Ohlfest JR. (2012) Increasing the efficacy of tumor cell vaccines by enhancing cross priming. Cancer Letters. 325: 155-64 |
| Olin MR, Andersen BM, Litterman AJ, et al. (2011) Oxygen is a master regulator of the immunogenicity of primary human glioma cells. Cancer Research. 71: 6583-9 |
| Olin MR, Andersen BM, Zellmer DM, et al. (2010) Superior efficacy of tumor cell vaccines grown in physiologic oxygen. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4800-8 |